Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Муллагалиев Арсен Арсенович
Observed names:
A. A. Mullagaliev,
A.A. Mullagaliev,
Arsen A. Mullagaliev,
Муллагалиев А.А.
Institutions:
Institute of Cytology and Genetics,
Siberian Branch of the Russian Academy of Sciences,
Institute of Clinical and Experimental Lymphology
Observed institutions:
Russian Academy of Sciences,
Institute of Cytology and Genetics,
Siberian Branch of the Russian Academy of Sciences,
Institute of Clinical and Experimental Lymphology
ORCID:
0000-0002-5213-5658
Observed ORCID:
0000-0002-5213-5658
OpenAlex ID:
A5078394083
Immuno-inflammatory rheumatic diseases and COVID-19: analysis of clinical outcomes according to the data of the register of patients of the Novosibirsk region receiving therapy with genetically engineered biological drugs
2022
·
Maxim A. Korolev
, Elena A. Letyagina
, et al.
·
Terapevticheskii arkhiv
·
13
PDF
The results of investigating the efficacy and safety of non-medical switching from the original rituximab to its biosimilar in rheumatoid arthritis patients (AMBIRA study)
2021
·
M. A. Korolev
, Yu. B. Ubshaeva
, et al.
·
Rheumatology Science and Practice
·
4
PDF
Results of a 12-Week Open-Label, Non-Interventional Study of the Efficacy and Safety of Olokizumab Therapy in Patients with Rheumatoid Arthritis after Switching from Anti-B-Cell Therapy during the SARS-CoV-2 Pandemic
2024
·
A. A. Akimova
, N. E. Banshchikova
, et al.
·
Doklady Biochemistry and Biophysics
·
3
Results of a 12-week open-label, non-interventional study of the efficacy and safety of olokizumab therapy in patients with rheumatoid arthritis after switching from anti-B-cell therapy during the SARS-CoV-2 pandemic
2023
·
A. A. Akimova
, N. E. Banshchikova
, et al.
·
Rheumatology Science and Practice
·
2
PDF
Results of a 24-week open-label, non-interventional study on the efficacy and safety of olokizumab therapy in patients with rheumatoid arthritis after switching from anti-B-cell therapy during the SARS-CoV-2 pandemic
2024
·
A. V. Fedorova
, N. E. Banshchikova
, et al.
·
Modern Rheumatology Journal
·
1
Evaluation of the efficacy and safety of intra-articular injection of platelet-rich plasma in patients with osteoarthritis of the knee joint
2025
·
N. E. Banshchikova
, Y. D. Kurochkina
, et al.
·
Сибирский научный медицинский журнал
PDF
Оценка эффективности и безопасности применения обогащенной тромбоцитами плазмы при внутрисуставном введении у больных остеоартритом коленного сустава
2025
·
Банщикова Надежда Евгеньевна
, Курочкина Юлия Дмитриевна
, et al.
·
Сибирский научный медицинский журнал
An experimental study of PEGylated interferon lambda-1 chronic toxicity
2024
·
L.A. Oleinik
, K.I. Ershov
, et al.
·
JOURNAL of SIBERIAN MEDICAL SCIENCES
PDF
Risk factors for the development of pneumonia in patients with immuno-inflammatory rheumatic diseases receiving GIBP in conditions of COVID-19
2023
·
Yu.D. Kurochkina
, M.A. Korolev
, et al.
·
Yakut Medical Journal
Show more works
View as search
Works count:
12
Citation count:
23
H-index:
3
I10-index:
1
Year
Topic
Type